Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC230716 Pilot Single-Arm, Pragmatic Trial Of In-Home Versus In-Clinic Subcutaneous Nivolumab Administration Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06265285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06265285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC230716 Pilot Single-Arm, Pragmatic Trial Of In-Home Versus In-Clinic Subcutaneous Nivolumab Administration Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
April 30, 2024
Completion date
May 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced esophageal squamous cell carcinoma, advanced renal cell carcinoma, clinical stage ii esophageal squamous cell carcinoma ajcc v8, clinical stage iib cutaneous melanoma ajcc v8, clinical stage iic cutaneous melanoma ajcc v8, clinical stage iii cutaneous melanoma ajcc v8, clinical stage iii esophageal squamous cell carcinoma ajcc v8, clinical stage iv cutaneous melanoma ajcc v8, clinical stage iv esophageal squamous cell carcinoma ajcc v8, esophageal carcinoma, gastroesophageal junction adenocarcinoma, hepatocellular carcinoma, locally advanced urothelial carcinoma, lung non-small cell carcinoma, malignant solid neoplasm, metastatic colorectal carcinoma, metastatic cutaneous melanoma, metastatic esophageal squamous cell carcinoma, metastatic head and neck squamous cell carcinoma, metastatic urothelial carcinoma, recurrent esophageal squamous cell carcinoma, recurrent head and neck squamous cell carcinoma, renal cell carcinoma, stage iii renal cell cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iv renal cell cancer ajcc v8, unresectable cutaneous melanoma, unresectable esophageal squamous cell carcinoma, unresectable urothelial carcinoma, urothelial carcinoma